1. Home
  2. GNE vs AURA Comparison

GNE vs AURA Comparison

Compare GNE & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genie Energy Ltd. Class B Stock

GNE

Genie Energy Ltd. Class B Stock

HOLD

Current Price

$14.03

Market Cap

359.1M

Sector

Utilities

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$7.50

Market Cap

419.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNE
AURA
Founded
2011
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Power Generation
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
359.1M
419.5M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
GNE
AURA
Price
$14.03
$7.50
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$16.00
$20.00
AVG Volume (30 Days)
57.8K
772.3K
Earning Date
05-04-2026
05-08-2026
Dividend Yield
2.19%
N/A
EPS Growth
95.65
N/A
EPS
0.11
N/A
Revenue
$425,202,000.00
N/A
Revenue This Year
$17.49
N/A
Revenue Next Year
$7.07
N/A
P/E Ratio
$128.91
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.69
$4.73
52 Week High
$28.47
$9.54

Technical Indicators

Market Signals
Indicator
GNE
AURA
Relative Strength Index (RSI) 50.36 48.84
Support Level $13.93 $5.94
Resistance Level $14.85 $7.68
Average True Range (ATR) 0.48 0.35
MACD 0.03 -0.08
Stochastic Oscillator 57.00 25.90

Price Performance

Historical Comparison
GNE
AURA

About GNE Genie Energy Ltd. Class B Stock

Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: